FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to dermatology, and can be used in the treatment of skin manifestations both in limited, and systemic scleroderma. To do this, against the background of complex therapy, ganciclovir is additionally intravenously administered in an amount of 250 mg per 100.0 ml of saline daily for 12–15 days, Grosprinosin (inosine pranobex) – two tablets three times a day for 10 days, and thioctic acid – intravenously or orally 600 mg daily for 10 days.
EFFECT: method allows to increase the effectiveness of treatment and to increase the duration of clinical remission of dermatosis.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIAGNOSING FUNCTIONAL PATHOLOGY OF GASTROINTESTINAL TRACT IN PATIENTS WITH ROSACEA | 2020 |
|
RU2751656C1 |
| METHOD OF LABORATORY DIAGNOSTICS OF FUNCTIONAL PATHOLOGY OF LIVER ON ADULTS WITH PSORIASIS | 2017 |
|
RU2678765C1 |
| METHOD OF TREATING CYTOMEGALOVIRUS INFECTION | 2013 |
|
RU2540474C2 |
| METHOD OF LEUKOENCEPHALITIS TREATMENT IN CHILDREN | 2007 |
|
RU2348411C2 |
| METHOD OF TREATING GENERALIZED CYTOMEGALOVIRUS INFECTION IN CHILDREN OF EARLY AGE | 2015 |
|
RU2602953C1 |
| METHOD OF TREATING LOCALISED SCLERODERMA | 2014 |
|
RU2573986C1 |
| METHOD FOR TREATING PATIENTS SUFFERING FROM UROGENITAL HERPES VIRUS INFECTION | 2001 |
|
RU2189793C1 |
| METHOD FOR ASSESSMENT OF ACTIVITY OF INFECTION CAUSED BY HERPES TYPE 4, 5 AND 6 IN CHILDREN | 2016 |
|
RU2639593C1 |
| METHOD FOR PREVENTION AND TREATMENT OF CHRONIC, FREQUENTLY RECURRENT HERPES VIRUS INFECTION | 2008 |
|
RU2373951C1 |
| RISK PREDICTION METHOD FOR RECURRENCE OF HERPES-ASSOCIATED EYE DISEASES | 2007 |
|
RU2345366C1 |
